Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Acquisitions (2021 - 2025)

Firefly Neuroscience has reported Acquisitions over the past 3 years, most recently at -$2.4 million for Q4 2025.

  • Quarterly results put Acquisitions at -$2.4 million for Q4 2025, down 3046.67% from a year ago — trailing twelve months through Dec 2025 was -$2.4 million (down 3146.67% YoY), and the annual figure for FY2021 was $7.3 million, changed.
  • Acquisitions for Q4 2025 was -$2.4 million at Firefly Neuroscience, down from -$75000.0 in the prior quarter.
  • Over the last five years, Acquisitions for AIFF hit a ceiling of $5.0 million in Q4 2021 and a floor of -$2.4 million in Q4 2025.
  • Median Acquisitions over the past 3 years was -$75000.0 (2024), compared with a mean of $869887.3.
  • Peak annual rise in Acquisitions hit 3046.67% in 2025, while the deepest fall reached 3046.67% in 2025.
  • Firefly Neuroscience's Acquisitions stood at $5.0 million in 2021, then crashed by 101.49% to -$75000.0 in 2024, then tumbled by 3046.67% to -$2.4 million in 2025.
  • The last three reported values for Acquisitions were -$2.4 million (Q4 2025), -$75000.0 (Q4 2024), and $5.0 million (Q4 2021) per Business Quant data.